Association of Mineral Bone Disorder With Decline in Residual Kidney Function in Incident Hemodialysis Patients
Open Access
- 14 October 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 35 (2) , 317-325
Abstract
Abnormalities of mineral bone disorder (MBD) parameters have been suggested to be associated with poor renal outcome in predialysis patients. However, the impact of those parameters on decline in residual kidney function (RKF) is uncertain among incident hemodialysis (HD) patients. We performed a retrospective cohort study in 13,772 patients who initiated conventional HD during 2007–2011 and survived six months of dialysis. We examined the association of baseline serum phosphorus levels with a decline in RKF. We also examined the association of baseline calcium, intact parathyroid hormone (PTH), and alkaline phosphatase (ALP) levels with a decline in RKF. Decline in RKF was assessed by estimated slope of renal urea clearance (KRU) over 6 months from HD initiation. Our cohort had a mean ± SD age of 62 ± 15 years; 64% were men, 57% were Caucasian, 65% had diabetes, and 51% had hypertension. The median (interquartile range, IQR) baseline KRU level was 3.4 (2.0, 5.2) mL/min/1.73 m2. The median (IQR) estimated 6‐month KRU slope was −1.47 (−2.24, −0.63) mL/min/1.73 m2 per 6 months. In linear regression models, higher phosphorus categories were associated with a steeper 6‐month KRU slope compared to the reference category (phosphorus 4.0 to <4.5 mg/dL). Lower calcium and higher intact PTH and ALP categories were also associated with a steeper 6‐month KRU slope compared to their respective reference groups (calcium 9.2 to <9.5 mg/dL; intact PTH 150 to <250 pg/mL; ALP <60 U/L). The increased number of parameter abnormalities had an additive effect on decline in RKF. Abnormalities of MBD parameters including higher phosphorus, intact PTH, and ALP and lower calcium levels were independently associated with decline in RKF in incident HD patients.Keywords
Funding Information
- NIH/NIDDK (K24-DK091419)
- Office of Research and Development of the Department of Veterans Affairs (IK2-CX 001266-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24‐DK091419)
This publication has 39 references indexed in Scilit:
- Is the decline of renal function different before and after the start of dialysis?Nephrology Dialysis Transplantation, 2013
- Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney DysfunctionClinical Journal of the American Society of Nephrology, 2011
- Contribution of Residual Function to Removal of Protein-Bound Solutes in HemodialysisClinical Journal of the American Society of Nephrology, 2011
- Role of Residual Renal Function in Phosphate Control and Anemia Management in Chronic Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Association of Residual Urine Output With Mortality, Quality of Life, and Inflammation in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) StudyAmerican Journal of Kidney Diseases, 2010
- 25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney DiseaseJournal of the American Society of Nephrology, 2009
- Association of Serum Alkaline Phosphatase with Coronary Artery Calcification in Maintenance Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcificationKidney International, 2008
- Presence of Abdominal Aortic Calcification Is Significantly Associated With All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2007